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questionnaire findings, in order to provide a deeper 
understanding of the processes involved and allow a separate 
methodology to either reinforce or reject findings. 
 
Results: Questionnaire response rate was 78%. 81.8% of 
radiographers who participated agreed that reflection is an 
essential part of their professional learning. 
Of the radiographers who responded 96% said they could 
recall engaging in informal reflection. Fewer could recall 
recently practicing formal reflection. When asked if they feel 
their work practice improved after reflecting informally 
89.5% of radiographers agreed. Compared to informal 
reflection, less agreed that engaging in formal structured 
reflection had improved their work practice (76.4%).  
Focus group data results suggest that radiographers believe 
informal reflection is an essential element of their 
professional learning, and that it has a direct beneficial 
impact on their patient care. There is a lack of consensus on 
the practice of formal reflection, with many radiographers 
citing barriers such as lack of time, training and evidence to 
support its use. 
 
Conclusion: This study has found that therapy radiographers 
within the Christie NHS Trust believe engaging in reflective 
practice directly benefits their professional work and, by 
inference, improves patient care. Informal refection is 
considered more effective and easier to employ. It should 
therefore be acknowledged by educators and professional 
bodies as the dominant reflective process.  
To encourage the adoption of formal reflective practice, 
researchers and theorists should work on unifying the 
paradigm around a more simplistic, focused approach. 
Further research investigating the impact of an appropriate 
reflective model within the radiotherapy clinical setting using 
a robust qualitative study design is recommended. 
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Purpose or Objective: We investigated the occurence of 
visual phosphenes during the irradiation of the head. Visual 
phosphenes may occur because of direct stimulation of the 
retina by ionising radiation or by the Cerenkov irradiation 
that is generated in the eyeball. These are 2 different 
physical processes with their own characteristic visual 
sensation for the patient. We hypothesise that the direct 
stimulation of the retina is perceived as flashes of light, 
whereas the Cerenkov effect is perceived as a coloured light 
source. These are also the 2 main visual phosphenes that 
patients report. The first objective of the research is to 
establish what percentage of patients perceives light flashes 
or coloured light. The second objective is to determine, if it 
is perceived, what percentage of treatment fractions the 
patient perceives light flashes or coloured light. The third 
objective is to determine whether there is a relation 
between the perception of light flashes and the dose to the 
retina, or whether such a relation exists between the 
perception of coloured light and the dose to the eyeball. 
 
Material and Methods: The inclusion criteria for the study 
were: treatment on the head, treatment plan with at least 3 
fractions, and an informed consent. The patient was asked to 
complete a survey after each treatment fraction. We 
specifically ask for the occurrence of flashes of light and/or 
the occurrence of coloured light. Moreover, we ask for a 
description of the perception. We distinguish between 6 MV 
(59 patients) or 10 MV (15 patients) treatment plans. The 
dose relation has been investigated for a subgroup of 17 
patients. 
 
Results: 1) Approximately 60% of the patients with 6 MV 
plans and about 70% of the patients with 10 MV plans observe 
light flashes or coloured light at least once during their 
treatment. Often both light flashes and coloured light are 
observed at the same fraction. However, it also occurs that 
only light flashes are observed or only coloured light is 
observed. 2) If light flashes or coloured light are perceived 
this occurs in approximately 70% of all treatment fractions 
for 6 MV beams, approximately 80% of treatment fractions for 
light flashes in 10 MV beams and approximately 90% of 
treatment fractions for coloured light in 10 MV beams. 3) The 
subgroup is too small to establish a dose relationship. 
However, below an average dose of 25 cGy on both retinas 
and both eyeballs almost no phosphenes are observed. For 
plans with an average dose of more than 150 cGy in one 
retina and more than 100 cGy in one eyeball, the patients in 
our subgroup perceive both phenomena at every fraction. 
 
Conclusion: We have characterized the occurrence of visual 
phosphenes in our clinic. A relatively large number of 
patients perceives these phenomena. A dose relationship 
cannot be established but seems to exist. 
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Purpose or Objective: With the introduction of a decision 
protocol for anatomical changes as observed on ConebeamCT 
(CBCT) images (traffic light protocol (TLP)), data such as, for 
example, actions in response to certain anatomical changes 
have been recorded in the open text area of the patient’s 
electronic treatment chart on a daily basis. Recording the 
data in this way is manageable for keeping track of changes 
during a treatment, but this method cannot easily be used for 
retrospective analysis for e.g. research purposes. Therefore, 
we have introduced a dedicated digital TLP log within the 
patient’s dossier, that enabled a clear and structured 
overview of the information gathered from the CBCT scans. 
In a retrospective study, the efficacy of this log was 
evaluated. 
 
Material and Methods: The TLP digital log was implemented 
and accommodated in the Mosaiq Oncology Information 
Management System. The log contains a separate format for 
each of the major target areas on which the TLP is used and 
does not contain any free text entry fields. For every CBCT 
acquisition a log entry is created. Within the log the user can 
register the relevant anatomical changes seen on the CBCT, 
by using drop down lists with fixed entries (e.g. bladder 
filling or tumour regression and the action taken (see figure). 
The actions are categorised by colour: Green (no action), 
Yellow (notification of the Medical Docter (MD) optional), 
Orange (action needed by the MD before next fraction) and 
Red (immediate action needed from the MD). During the 
period of data gathering the digital TLP was made available 
for five target areas: Breast, Sarcoma, Lung, Gynaecology 
and Urology. The digital log was retrospectively evaluated on 
120 patients (40 for urology, 20 for all other target areas) 
with a CBCT imaging protocol treated from January 2013 to 
December 2013. The use of the digital log in clinical practice 
was evaluated using a questionnaire filled in by the RTTs. 
During the data gathering, a total of 1806 CBCT scans were 
reviewed and registered in the digital log. All of these scans 
were assessed with the TLP to determine the course of 
action. In this period, all action codes were registered and 
recorded. 




Results: Using the digital log, the data concerning the TLP 
can be stored in a structured way, rather than in open text 
parts of a patient’s dossier. The action codes regarding the 
anatomical changes that are present in the log showed a 
clear overview of possible variations during treatment. The 
RTTs scored an average of 7.8/10 in the questionnaire on the 
digital log overview. In succession, this overview showed a 
clear course of action regarding these anatomical changes 
using the TLP. 
 
Conclusion: The implementation and use of a digital log 
improves the overview of the anatomical changes observed 
on CBCT during radiotherapy. Moreover, the data gathered 
within the log can retrospectively be used for clinical or 
research questions regarding clinical IGRT decisions for a 
specific target area. 
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Purpose or Objective: Vestibular schwannomas (acoustic 
neuromas) are common benign tumors that arise from the 
Schwann cells of the vestibular nerve. Management options 
include observation with neuroradiological follow-up, 
microsurgical resection or stereotactic radiotherapy (SRS). 
The aim of the study was to evaluate tumor size and 
treatment tolerance of patients treated with CyberKnife (CK) 
radiosurgery for vestibular schwannoma (VS). 
 
Material and Methods: Between 2011 and 2014, 96 patients 
with 100 vestibular schwannomas were treated with SRS using 
CK. The vestibular schwannomas of 5 patients were 
associated with type II neurofibromatosis. Twenty patients 
were operated on before radiosurgery. All patients had more 
than one year follow-up. The median age at the time of 
treatment was 59 ( range 21-88 years). Median tumor 
diameter was 18 mm (range 3-48 mm) and the median 
prescribed dose was 16 Gy (12-21 Gy). In 29 patients, single 
dose of 12-18 Gy was delivered, in 31 total dose of 12-16 Gy 
was delivered with two fractions and the remaining 40 
patients were treated with 15-21 Gy delivered in 3 fractions 
baseline. Hearing was classified according to the Gardner 
Robertson grading scale (48% of patients had serviceable 
hearing).  
 
Results: At 12 month after SRS we observed that :15% of 
tumors slightly expanded, in 8% patients slight expansion of 
tumor followed by regression, 11% of tumors increased in 
size, but then remained stable, 58% were stable in size and 
8% responded to therapy. Overall, tumor swelling was, thus, 
observed in 34% of patients. At first year no patient required 
neurosurgical intervention due to tumor progression or 
brainstem compression symptoms. 77% patients had stable 
level of hearing after SRS, 9% declared improvement and 14% 
worsening of hearing. The rate of complications was very 
low, with most consisting of a transient worsening of 
preexisting symptoms. At the last assessment, full facial and 
trigeminal nerve function was preserved in 95% and 98% of 
patients, respectively; the only facial deficit (House-
Brackmann grade III) occurred in patient who received a 
single dose of 18 Gy in one fraction early in our experience, 
the remaining were mild, grade II dysfunctions. None of the 
patients treated with doses lower than 13 Gy experienced 
facial or trigeminal neuropathy. 
 
Conclusion: Cyber Knife radiosurgery is a safe and effective 
treatment for VS characterized by high probability of 
retaining functional hearing and facial and trigeminal nerve 
function preservation. In about one third of patients a tumor 
swelling after treatment is observed but reliable tumor 
control and persistence of neural dysfunctions assessment 
requires longer follow-up. 
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Purpose or Objective: Soft tissue sarcomas are rare 
malignancies, commonly arising in limbs, with an annual 
incidence of 3,298 cases in the UK in 2010. Their rarity leads 
to a lack of published data and experience in limb 
immobilisation for radiotherapy planning. The IMRiS trial is a 
phase II study of intensity modulated radiotherapy (IMRT) in 
primary bone and soft tissue sarcoma, due to open in late 
2015. As part of a pre-trial quality assurance (PT QA) 
programme, we report on the current UK practice of limb 
soft tissue sarcoma (LSTS) immobilization and the 
significance for multi-centre trial recruitment. 
 
Material and Methods: A facility questionnaire (FQ) was 
circulated to 29 IMRiS centres to investigate variation in 
immobilisation devices (ID), planning techniques, and imaging 
protocols. A workshop was held to address limb sarcoma 
immobilisation and patient set up. Robustness of patient 
setup at each centre was evaluated based on setup audits, 
frequency of imaging and the number of patients (pts) 
treated per centre per annum. 
 
Results: 27 questionnaires were returned. Less than 1/3 of 
the responders routinely treat their pts with IMRT (8/27). The 
remaining 2/3 have little or no experience with IMRT for 
LSTS. Vacuum bags are currently the most popular ID (9/27), 
followed by thermoplastic shells (7/27), limb boards (5/27), 
other devices (3/27) of which 2 used in-house developed and 
customisable devices, and 1 used common positioning pads. 2 
centres combined the use of vacuum bag and shell. 9 centres 
had audited their setup. However, only 4 had calculated their 
setup margins on the basis of systematic and random error. 
The majority of centres follow the recommendations to 
perform imaging on days 1 to 5 and then weekly. 6 centres 
perform daily imaging (all 6 treat LSTS with IMRT). Of 6 
centres with a high level of setup robustness, 3 are IMRT 
centres. On average centres treat 24 pts annually (range 3-
53). Currently over half the centres treat less than the 
calculated average number of pts. 
 
Conclusion: The results from the FQ and workshop 
demonstrate variations in treatment modality, ID and imaging 
frequency across the UK. 70% of IMRiS participating centres 
will be implementing or further developing IMRT in order to 
treat LSTS in the study. This will require a change in 
treatment modality (from 3DCRT to IMRT) in 9 centres. 
Comprehensive PT QA is required to ensure quality in a trial 
to be run at centres with such different levels of experience. 
